A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

SELLAS Life Sciences Virtual R&D Day -- October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...

Across Africa's fastest-growing markets, compliance has transitioned from a procedural necessity to one of the strongest ...

The Central Bank has imposed ‘administrative penalties’ on several financial institutions, including two banks, for ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia ...

Bitcoin led a selective 2025 crypto market as XRP, Zcash, and Algorand rose on regulation, privacy, and tokenization.

In the evolving ecosystem of cryptocurrency platforms and exchange services, stablecoins have become a focal point for ...

Crypto account frozen? Learn who holds legal leverage, the commercial stakes of stalled payments, and the credible path to ...

Recognition at the Outlook Business Awards highlights Zrika’s role in transforming compliance into a growth enabler, ...

Sellas Life Sciences Group Inc (NASDAQ:SLS) stock surged 16.9% on Monday after the company provided an update on its Phase 3 REGAL trial evaluating GPS as a maintenance therapy for acute myeloid ...

A critical aspect of no deposit bonus casinos is the wagering requirement attached to promotional funds. Industry data ...